Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2145 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.070 | 0.714 | 7 | 2009 | 2019 | ||||||
Malignant neoplasm of breast
|
2154 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.070 | 0.714 | 7 | 2009 | 2019 | ||||||
Polycystic Ovary Syndrome
|
307 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.050 | 0.600 | 5 | 2015 | 2019 | ||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
1598 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.040 | 1.000 | 4 | 2012 | 2018 | ||||||
Osteoporosis
|
168 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.040 | 1.000 | 4 | 2014 | 2018 | ||||||
Obesity
|
900 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.030 | 1.000 | 3 | 2014 | 2018 | ||||||
Tuberculosis
|
306 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.030 | 1.000 | 3 | 2016 | 2019 | ||||||
Asthma
|
714 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2020 | 2020 | ||||||
Carcinoma, Ovarian Epithelial
|
321 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2007 | 2018 | ||||||
Coronary Artery Disease
|
1022 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2009 | 2019 | ||||||
Dermatitis, Atopic
|
137 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2016 | 2020 | ||||||
Diabetes Mellitus, Insulin-Dependent
|
388 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 2 | 2013 | 2019 | |||||||
Eczema
|
155 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2016 | 2020 | ||||||
Graves Disease
|
252 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2005 | 2018 | ||||||
HIV-1 infection
|
62 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2008 | 2010 | ||||||
Kidney Calculi
|
68 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2016 | 2019 | ||||||
Lupus Erythematosus, Systemic
|
635 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2017 | ||||||
Malignant neoplasm of prostate
|
861 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 0.500 | 2 | 2017 | 2018 | ||||||
Metabolic Syndrome X
|
477 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 0.500 | 2 | 2018 | 2019 | ||||||
Neoplasms
|
1571 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2011 | 2016 | ||||||
Nephrolithiasis
|
68 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2016 | 2019 | ||||||
Osteoporosis, Postmenopausal
|
25 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||||
Parkinson Disease
|
751 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2017 | 2019 | ||||||
Prostate carcinoma
|
858 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 0.500 | 2 | 2017 | 2018 | ||||||
Tuberculosis, Pulmonary
|
171 | 0.542 | 0.760 | 12 | 47846052 | intron variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2017 | 2019 |